Cobra-120 is a synthetic inhibitor of the enzyme phosphodiesterase type 5. It is formulated as an oral tablet intended to treat pulmonary hypertension. By blocking phosphodiesterase 5, the drug increases levels of cyclic guanosine monophosphate in vascular smooth muscle cells. This leads to relaxation of pulmonary arterial walls and reduces vascular resistance. The resulting decrease in pulmonary pressure improves exercise capacity in affected patients. The effect is achieved through selective binding to the catalytic site of the enzyme without influencing other isoforms.

Cobra-120 is a synthetic peptide that selectively binds to the ectodomain of the growth factor receptor involved in tumor cell proliferation. Its pharmacological profile includes a long circulating half-life due to polyethylene glycol conjugation that protects it from rapid degradation. The drug exhibits linear dose-response behavior and demonstrates predictable absorption after subcutaneous administration. Upon binding its target receptor it initiates a cascade that blocks downstream signaling required for angiogenesis and cell survival. This blockade suppresses the production of pro-inflammatory cytokines and reduces the infiltration of immune cells that support tumor growth. The resulting inhibition of angiogenesis limits the supply of nutrients to malignant tissues and promotes regression of established lesions. Overall the mechanism of action relies on precise molecular recognition that translates into a therapeutic effect of tumor control without systemic toxicity.

Headache is frequently reported as a reaction to Cobra-120. Nausea and mild stomach discomfort may occur shortly after taking the medication. Dizziness or lightheadedness can be experienced especially during the first doses. Flushing of the skin is another common response observed in users. Dry mouth often accompanies treatment with Cobra-120. Fatigue or general tiredness may be noted by some individuals. Mild tremors have been documented but remain infrequent.

Cobra-120 may cause drowsiness in some users. Headaches are reported as a frequent side effect. Nausea can occur shortly after ingestion. Some people experience a dry feeling in the mouth. Dizziness or light headedness may be observed. An increased heart rate has been noted in certain cases. Blurred vision may affect some individuals. Skin rashes can develop as an allergic reaction.